Paclitaxel induces pyroptosis by inhibiting the volumesensitive chloride channel leucinerich repeatcontaining 8a in ovarian cancer cells.
Oncol Rep
; 49(6)2023 06.
Article
en En
| MEDLINE
| ID: mdl-37083067
Pyroptosis is a newly identified form of cell death, morphologically characterized by excessive cell swelling. In the present study, paclitaxel (PTX) combined with platinum were used as firstline chemotherapy, against ovarian cancer cells by inducing multiple types of cell death. However, it remains unclear whether PTX can induce pyroptosis in ovarian cancer cells. It was recently reported that PTX inhibited chloride channels, an inhibition known to cause cell swelling. In the present study, it was first verified that pyroptosislike cell death, as well as cleavedcaspase3 and cleavedgasdermin E (GSDME) were induced by PTX in A2780 ovarian cancer cells. PTX inhibited the background and hypotonicityactivated chloride currents, promoted intracellular chloride ion accumulation, those manifestations are similar to those of the classic volumeregulatory anion channel (VRAC) blocker, 4(2butyl6,7dichloro2cy-clopentylindan1on5yl) oxobutyric acid (DCPIB). Of note, both DCPIB and the downregulation of VRAC constituent protein leucinerich repeatcontaining 8a themselves could not induce persisted cell swelling and pyroptosislike phenotypes. However, they could enhance the effects of PTX in inducing pyroptosislike phenotypes, such as marked cell swelling, cell membrane rupture and excessive activation of caspase3 and GSDME Nterminal fragment, which ultimately caused marked pyroptosis in A2780 cells. These findings revealed a potential mechanism of PTX and offered new insights into the effects of a synergistical combination of PTX and VRACs blockers in ovarian cancer chemotherapy.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Ováricas
/
Paclitaxel
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Límite:
Female
/
Humans
Idioma:
En
Revista:
Oncol Rep
Asunto de la revista:
NEOPLASIAS
Año:
2023
Tipo del documento:
Article
Pais de publicación:
Grecia